Protective ileostomy creation after anterior resection of the rectum

Autor: Andrea, Balla, Federica, Saraceno, Marika, Rullo, Salvador, Morales-Conde, Eduardo M, Targarona Soler, Salomone, Di Saverio, Mario, Guerrieri, Pasquale, Lepiane, Nicola, Di Lorenzo, Michel, Adamina, Isaias, Alarcón, Alberto, Arezzo, Jesus, Bollo Rodriguez, Luigi, Boni, Sebastiano, Biondo, Francesco Maria, Carrano, Manish, Chand, John T, Jenkins, Justin, Davies, M, Chir, Salvadora Delgado, Rivilla, Paolo, Delrio, Ugo, Elmore, Eloy, Espin-Basany, Alessandro, Fichera, Blas Flor, Lorente, Nader, Francis, Marcos Gómez, Ruiz, Dieter, Hahnloser, Eugenio, Licardie, Carmen, Martinez, Monica, Ortenzi, Yves, Panis, Carlos, Pastor Idoate, Alessandro M, Paganini, Miguel, Pera, Roberto, Perinotti, Daniel A, Popowich, Timothy, Rockall, Riccardo, Rosati, Alberto, Sartori, Daniele, Scoglio, Mostafa, Shalaby, Vicente, Simó Fernández, Neil J, Smart, Antonino, Spinelli, Patricia, Sylla, Pieter J, Tanis, Javier, Valdes Hernandez, Steven D, Wexner, Pierpaolo, Sileri

Publikováno v: Colorectal Disease, 25(4), 647-659. Wiley-Blackwell Publishing Ltd
Colorectal disease, vol. 25, no. 4, pp. 647-659
Colorectal disease. Wiley-Blackwell

Aim: The choice of whether to perform protective ileostomy (PI) after anterior resection (AR) is mainly guided by risk factors (RFs) responsible for the development of anastomotic leakage (AL). However, clear guidelines about PI creation are still la

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba259e1017fe3477bb66232f953a1274
https://doi.org/10.1111/codi.16454

Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ('ugly') locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)

Autor: van den Berg, K., Schaap, D. P., Voogt, E. L. K., Buffart, T. E., Verheul, H. M. W., de Groot, J. W. B., Verhoef, C., Melenhorst, J., Roodhart, J. M. L., de Wilt, J. H. W., van Westreenen, H. L., Aalbers, A. G. J., van 't Veer, M., Marijnen, C. A. M., Vincent, J., Simkens, L. H. J., Peters, N. A. J. B., Berbée, M., Werter, I. M., Snaebjornsson, P., Peulen, H. M. U., van Lijnschoten, I. G., Roef, M. J., Nieuwenhuijzen, G. A. P., Bloemen, J. G., Willems, J. M. W. E., Creemers, G. J. M., Nederend, J., Rutten, H. J. T., Burger, J. W. A.

Publikováno v: BMC Cancer, 22(1):957. BioMed Central Ltd
BMC Cancer, 22(1):957. BioMed Central
BMC Cancer, 22
BMC Cancer, 22(1):957. BioMed Central Ltd.
BMC Cancer, 22, 1
van den Berg, K, Schaap, D P, Voogt, E L K, Buffart, T E, Verheul, H M W, de Groot, J W B, Verhoef, C, Melenhorst, J, Roodhart, J M L, de Wilt, J H W, van Westreenen, H L, Aalbers, A G J, van 't Veer, M, Marijnen, C A M, Vincent, J, Simkens, L H J, Peters, N A J B, Berbée, M, Werter, I M, Snaebjornsson, P, Peulen, H M U, van Lijnschoten, I G, Roef, M J, Nieuwenhuijzen, G A P, Bloemen, J G, Willems, J M W E, Creemers, G J M, Nederend, J, Rutten, H J T & Burger, J W A 2022, ' Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer : study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT) ', BMC Cancer, vol. 22, no. 1, 957, pp. 957 . https://doi.org/10.1186/s12885-022-09947-w

Background The presence of mesorectal fascia (MRF) invasion, grade 4 extramural venous invasion (EMVI), tumour deposits (TD) or extensive or bilateral extramesorectal (lateral) lymph nodes (LLN) on MRI has been suggested to identify patients with ind

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5e5e66763b1aab2bcbd20c945d69797
https://doi.org/10.1186/s12885-022-09947-w

Does IBD Portend Worse Outcomes in Patients with Rectal Cancer? A Case-Matched Analysis

Autor: Amy L. Lightner, Ahmad Alsughayer, Kellie L. Mathis, Nicholas P. McKenna, M. Petersen, Fabian Grass

Publikováno v: Diseases of the colon and rectum, vol. 63, no. 9, pp. 1265-1275

Background Patients with IBD are at increased risk for developing colorectal cancer. However, overall survival and disease-free survival for rectal cancer alone in patients with IBD has not been reported. Objective This study aimed to determine overa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d9d94532dd1a38a327bb75e4c2c6965
https://pubmed.ncbi.nlm.nih.gov/33216497

Health-related quality of life in rectal cancer patients undergoing neoadjuvant chemoradiation with delayed surgery versus short-course radiotherapy with immediate surgery : a propensity score-matched cohort study

Autor: A. H. W. Schiphorst, Niels A.T. Wijffels, Esther C. J. Consten, Joost T. Heikens, Alice M. Couwenberg, Miriam Koopman, Wilhemina M.U. van Grevenstein, Martijn Intven, J.P.M. Burbach, Helena M. Verkooijen, Anke B. Smits

Publikováno v: Acta Oncologica, 58(4), 407. Informa Healthcare

Background: Neoadjuvant chemoradiation with delayed surgery (CRT-DS) and short-course radiotherapy with immediate surgery (SCRT-IS) are two commonly used treatment strategies for rectal cancer. However, the optimal treatment strategy for patients wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20e397593ecb3cefadb3cc4db3a2b3e2
https://dspace.library.uu.nl/handle/1874/388515

Initial Staging of Locally Advanced Rectal Cancer and Regional Lymph Nodes

Autor: Anna Dorothea Wagner, Dieter Hahnloser, Sabine Schmidt, Reto Meuli, John O. Prior, Vincent Dunet, Milena Cerny

Publikováno v: Clinical Nuclear Medicine
Clinical nuclear medicine, vol. 41, no. 4, pp. 289-295

Colorectal cancer is the second most common cancer, with 447,000 new cases per year in 2012, and the third most common cause of death from cancer in Europe. Rectal carcinoma represents 40% to 50% of colorectal cancers, among them 95% being adenocarci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e02a99642f429b93e6db396c88e5ce3
https://doi.org/10.1097/rlu.0000000000001172